Insider Transactions in Q2 2024 at Arcus Biosciences, Inc. (RCUS)
Insider Transaction List (Q2 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 15
2024
|
Carolyn C. Tang General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
4,182
-3.62%
|
$66,912
$16.97 P/Share
|
|
Jun 15
2024
|
Jennifer Jarrett Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
12,670
-5.87%
|
$202,720
$16.97 P/Share
|
|
Jun 15
2024
|
Juan C. Jaen President |
SELL
Payment of exercise price or tax liability
|
Direct |
6,969
-2.04%
|
$111,504
$16.97 P/Share
|
|
Jun 15
2024
|
Terry J Rosen Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
12,670
-0.32%
|
$202,720
$16.97 P/Share
|
|
Jun 06
2024
|
Nicole Lambert Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,400
+25.93%
|
-
|
|
Jun 06
2024
|
Antoni Ribas Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,400
+21.68%
|
-
|
|
Jun 06
2024
|
Andrew J Perlman Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,400
+22.27%
|
-
|
|
Jun 06
2024
|
Patrick Machado Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,400
+24.93%
|
-
|
|
Jun 06
2024
|
Kathryn E Falberg Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,400
+13.19%
|
-
|
|
Jun 06
2024
|
David L. Lacey Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,400
+12.72%
|
-
|
|
Jun 06
2024
|
Yasunori Kaneko Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,400
+35.59%
|
-
|